Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Iron Deficiency Injectable Market Today And What Is Its Future Size?

There has been substantial growth in the iron deficiency injectable market over the past few years. The market, worth $14.06 billion in 2024, is projected to reach a value of $15.22 billion by 2025, representing a compound annual growth rate (CAGR) of 8.3%. The significant growth observed during the historical period is mainly due to the rise in iron deficiency anemia treatments, an increase in bariatric surgery patients, and a growth in the number of pediatric, adolescent, and pregnant patients.

The market size for injectable iron deficiency is projected to experience a swift expansion in the upcoming years. It is anticipated to rise to $22.81 billion by 2029, with a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this growth over the forecast period include the ageing population, worldwide health initiatives, governmental programs, the proliferation of treatments for chronic diseases, and speedy iron replenishment. Key trends during this period will be spearheaded by progress in iron formulations, digital healthcare solutions, advances in injectable therapy for iron deficiency, and the acceptance of iron-based medications.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12907&type=smp

Which Demand Drivers Are Strengthening The Iron Deficiency Injectable Market?

The ascent in the occurrence of polycystic ovary syndrome (PCOS) is predicted to catalyze the expansion of the iron deficiency injectables market in future. PCOS is a prevalent hormonal imbalance, primarily impacting women in their child-bearing years. It can lead to an accumulation of iron, causing significant blood loss during menstruation and leading to anemia. This condition can be treated with injections for iron deficiency. The World Health Organization, a US-based health-focused entity, indicated in June 2023 that globally, PCOS impacts approximately 8–13% of women in their reproductive age, 70% of whom are yet to be diagnosed. Hence, the rising instances of PCOS triggers the growth of the iron deficiency injectables market.

Which Segment Accounts For The Largest Share In The Iron Deficiency Injectable Market?

The iron deficiency injectablemarket covered in this report is segmented –

1) By Type: Iron Dextran; Iron Sucrose; Ferric Carboxymaltose

2) By Branded or Generics: Branded; Generics

3) By Application: Chronic Kidney Disease; Inflammatory Bowel Disease; Cancer; Other Applications

4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users

Subsegments:

1) By Iron Dextran: Low Molecular Weight Iron Dextran; High Molecular Weight Iron Dextran

2) By Iron Sucrose: Venofer

3) By Ferric Carboxymaltose: Injectafer; Ferinject

Which Long-Term Trends Will Play A Crucial Role In The Iron Deficiency Injectable Market?

Prominent firms in the iron deficiency injectables market, such as INJECTAFER, are innovating new treatment options to maintain their market standing. In June 2023, an American healthcare firm called Daiichi Sankyo Company alongside American Regent Inc., a company that manufactures injectables also in the US, launched a product named INJECTAFER (ferric carboxymaltose injection) specifically for iron deficiency. This product was authorized by the Food And Drug Administration, a government agency located in the US. It stands as the first and singular intravenous iron substitute therapy that the FDA has approved for adult patients suffering from steady and ongoing heart failure. INJECTAFER underwent more than 40 clinical trials with over 8,800 participants across numerous countries. This recent authorization enhances the already proven and successful use of INJECTAFER in both adult and pediatric patients suffering from iron-deficient anemia and heart failure.

Which Companies Hold A Competitive Edge In The 643 Market?

Major companies operating in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH, Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/iron-deficiency-injectable-global-market-report

Which Region Is Forecasted To Lead The Iron Deficiency Injectable Market In The Coming Years?

North America was the largest region in the iron deficiency injectable market in 2024. The regions covered in iron deficiency injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12907&type=smp

Browse Through More Reports Similar to the Global Iron Deficiency Injectable Market 2025, By The Business Research Company

Hemoglobin A1C Testing Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Hemoglobin Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model